Progressive Care, Inc. (RXMD)
USD 2.11
(5.5%)
USD 2.11
(5.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 49.72 Million | 40.6 Million | 38.85 Million | 38.93 Million | 32.62 Million | 20.93 Million |
| Cost of Revenue | 34.56 Million | 30.89 Million | 28.67 Million | 29.97 Million | 24.66 Million | 16.24 Million |
| Gross Profit | 15.16 Million | 9.7 Million | 10.17 Million | 8.96 Million | 7.96 Million | 4.68 Million |
| Operating Expenses | 32.68 Million | 10.2 Million | 11.2 Million | 9.98 Million | 8.76 Million | 6.18 Million |
| Selling, General and Administrative Expenses | 13.68 Million | 12.28 Million | 11.2 Million | 9.98 Million | 8.76 Million | 6.18 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 29.18 Million | -2.07 Million | - | - | 143.00 | - |
| Cost and Expenses | 67.24 Million | 41.1 Million | 39.88 Million | 39.95 Million | 33.42 Million | 22.43 Million |
| Operating Income | -124 Thousand | -502.8 Thousand | -1.03 Million | -1.01 Million | -794.92 Thousand | -1.54 Million |
| Interest Expense | - | 797.71 Thousand | 1.39 Million | 1.7 Million | 1.24 Million | 302.83 Thousand |
| Income Tax Expense | -4.76 Million | 866.00 | 1.39 Million | 6780.00 | 2689.00 | 1650.00 |
| Earnings before Tax | -19.41 Million | -5.9 Million | 217.99 Thousand | -1.44 Million | -2.5 Million | -1.62 Million |
| Net Income | -14.64 Million | -5.9 Million | -1.17 Million | -1.44 Million | -2.5 Million | -1.62 Million |
| Earnings Per Share Basic | -2.36 | -2.03 | -0.45 | -0.63 | -1.16 | -0.78 |
| Earnings Per Share Diluted | -2.36 | -2.03 | -0.38 | -0.63 | -1.16 | -0.78 |
| Weighted Average Shares Outstanding | 6.19 Million | 2.91 Million | 2.6 Million | 2.31 Million | 2.15 Million | 2.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 6.19 Million | 2.91 Million | 3.09 Million | 2.31 Million | 2.15 Million | 2.09 Million |
| Gross Margin | 0.30 | 0.24 | 0.26 | 0.23 | 0.24 | 0.22 |
| EBIT Margin | 0.03 | -0.05 | -0.01 | -0.00 | -0.01 | -0.06 |
| Profit Margin | -0.29 | -0.15 | -0.03 | -0.04 | -0.08 | -0.08 |
| EBITDA | 1.47 Million | -1.86 Million | -468.47 Thousand | -163.25 Thousand | -336.43 Thousand | -1.16 Million |
| Earnings Before Tax Margin | -0.00 | -0.01 | -0.03 | -0.03 | -0.02 | -0.07 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 13.47 Million | 14.62 Million | 49.72 Million | 14.41 Million | 12.35 Million | 11.55 Million |
| Cost of Revenue | 11.73 Million | 13.55 Million | 43.61 Million | 12.61 Million | 8.57 Million | 7.99 Million |
| Gross Profit | 1.74 Million | 1.06 Million | 6.1 Million | 1.8 Million | 3.78 Million | 3.55 Million |
| Operating Expenses | 1.25 Million | 1.33 Million | 6.23 Million | 1.2 Million | 5.13 Million | 2.92 Million |
| Selling, General and Administrative Expenses | 1.25 Million | 1.33 Million | - | 1.2 Million | 4.43 Million | 2.92 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 4.31 Million | -3.06 Million | 29.18 Million | 7.51 Million | 2.86 Million | 12 Thousand |
| Cost and Expenses | 12.98 Million | 14.89 Million | 49.85 Million | 13.82 Million | 13.71 Million | 10.91 Million |
| Operating Income | 493 Thousand | -265 Thousand | -124 Thousand | 596.1 Thousand | -1.35 Million | 624.17 Thousand |
| Interest Expense | 17 Thousand | 16 Thousand | - | 15.73 Thousand | 38.26 Thousand | 64.84 Thousand |
| Income Tax Expense | - | 776.72 Thousand | - | 2.00 | 21.58 Thousand | 64.84 Thousand |
| Earnings before Tax | -9.27 Million | -372 Thousand | -19.41 Million | -13.27 Million | -1.37 Million | -4.63 Million |
| Net Income | -9.27 Million | -372 Thousand | -19.41 Million | -13.27 Million | -1.37 Million | -4.63 Million |
| Earnings Per Share Basic | -1.49 | -0.06 | - | -2.13 | -0.22 | -1.05 |
| Earnings Per Share Diluted | -1.49 | -0.06 | - | -2.13 | -0.22 | -1.05 |
| Weighted Average Shares Outstanding | 6.24 Million | 6.24 Million | 6.22 Million | 6.22 Million | 6.17 Million | 4.42 Million |
| Weighted Average Shares Outstanding (Diluted) | 6.24 Million | 6.24 Million | 6.22 Million | 6.22 Million | 6.17 Million | 4.42 Million |
| Gross Margin | 0.13 | 0.07 | 0.12 | 0.13 | 0.31 | 0.31 |
| EBIT Margin | 0.09 | 0.04 | - | 0.10 | -0.05 | 0.07 |
| Profit Margin | -0.69 | -0.03 | -0.39 | -0.92 | -0.11 | -0.40 |
| EBITDA | 1.27 Million | 555 Thousand | - | 1.41 Million | -589.54 Thousand | 756.98 Thousand |
| Earnings Before Tax Margin | 0.04 | -0.02 | -0.00 | 0.04 | -0.11 | 0.05 |
MOREPENLAB
GBLX
MOTILALOFS
PHVS
TI
LXCHEM